Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.
Asmaa A AshourAmal Hassan El-KamelDoaa A AbdelmonsifHoda M KhalifaAlyaa A RamadanPublished in: International journal of nanomedicine (2021)
The modified TSIIA-LNCs could be regarded as promising novel targeted nanomedicines for effective management of liver fibrosis.